Archives of Toxicology

, Volume 68, Issue 9, pp 588–594 | Cite as

Inhalation toxicokinetics of butoxyethanol and its metabolite butoxyacetic acid in the male Sprague-Dawley rat

  • Gunnar Johanson
Original Investigations
Received:
Accepted:

Abstract

A total of 16 male Sprague-Dawley rats were continuously exposed to 20 ppm or 100 ppm butoxyethanol (BE) vapor for 1, 2, 3, 4, 6, 8, 10, or 12 days. Urine was collected in 24-h intervals and stored at −70°C. At the end of the exposure the animals were euthanized by decapitation and tissue samples of blood, muscle, liver and were rapidly collected and frozen to −70°C. The samples were later derivatized and analyzed for BE and its major metabolite butoxyacetic acid (BAA) by electron capture gas chromatography. BE and BAA were rapidly distributed to the tissues examined. The concentration of BE in blood was slightly higher, and that of BAA markedly higher than in other tissues, indicating weak (BE) and pronounced (BAA) blood protein binding, respectively. BE was efficiently metabolized and the blood clearance averaged 2.6 l/h per kg, corresponding to a hepatic extraction ratio of about 0.75. The renal clearance of BAA (average 0.53 l/h per kg) corresponded to approximately 15% of the renal blood flow. The kinetics of BE and BAA were linear up to 100 ppm. There were no clear indications of changes in the toxicokinetics, such as metabolic induction or inhibition of metabolism or excretion, during the course of the exposure. The recovery of BAA in urine was 64% of the calculated inhaled amount of BE, on an equimolar basis.

Key words

Analysis Butoxyacetic acid Butoxyethanol Gas chromatography Glycol ethers Metabolism Rat 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arms AD, Travis CC (1988) Reference physiological parameters in pharmacokinetic modelling. EPA/600/6-88/004. US Environmental Protection AgencyGoogle Scholar
  2. Bartnik FG, Reddy AK, Klecak G, Zimmermann V, Hostynek JJ, Kunstler K (1987) Percutaneous absorption, metabolism, and hemolytic activity of n-butoxyethanol. Fundam Appl Toxicol 8: 59–70PubMedCrossRefGoogle Scholar
  3. Carpenter CP, Pozzani UC, Weil CS, Nair JH, Keck GA, Smyth Jr HF (1956) The toxicity of butyl cellosolve solvent. Arch Ind Health 14: 114–131Google Scholar
  4. Dodd DE, Snellings WM, Maronpot RR, Ballantyne B (1983) Ethylene glycol monobutyl ether: acute, 9-day, and 90-day vapor inhalation studies in Fischer 344 rats. Toxicol Appl Pharmacol 68: 405–414PubMedCrossRefGoogle Scholar
  5. Dugard PH, Walker M, Mawdsley SJ, Scott RC (1984) Absorption of some glycol ethers through human skin in vitro. Environ Health Perspect 57: 193–197PubMedCrossRefGoogle Scholar
  6. Fox M, Cox W, Ball T, Tashiro M (1989) CEH Marketing research report. Glycol ethers. Chemical Economics Handbook — SRI International, Stanford Research Institute, Menlo Park, Calif.Google Scholar
  7. Ghanayem BI (1989) Metabolic and cellular basis of 2-butoxyethanolinduced hemolytic anemia in rats and assessment of human risk in vitro. Biochem Pharmacol 38: 1679–1684PubMedCrossRefGoogle Scholar
  8. Ghanayem BI, Burka LT, Matthews HB (1987a) Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: role of alcohol and aldehyde dehydrogenases. J Pharmacol Exp Ther 242: 222–231PubMedGoogle Scholar
  9. Ghanayem BI, Burka LT, Sanders JM, Matthews HB (1987b) Metabolism and disposition of ethylene glycol monobutyl ether (2-butoxyethanol) in rats. Drug Metab Dispos 15: 478–484PubMedGoogle Scholar
  10. Ghanayem BI, Sanders JM, Clark A-M, Bailer J, Matthews HB (1990) Effects of dose, age, inhibition of metabolism and elimination on the toxicokinetics of 2-butoxyethanol and its metabolites. J Pharmacol Exp Ther 253: 136–143PubMedGoogle Scholar
  11. Ghanayem BI, Sanchez IM, Matthews HB (1992) Development of tolerance to 2-butoxyethanol-induced hemolytic anemia and studies to elucidate the underlying mechanisms. Toxicol Appl Pharmacol 112: 198–206PubMedCrossRefGoogle Scholar
  12. Grant D, Sulsh S, Jones HB, Gangolli SD, Butler WH (1985) Acute toxicity and recovery in the hemopoietic system of rats after treatment with ethylene glycol monomethyl and monobutyl ethers. Toxicol Appl Pharmacol 77: 187–200PubMedCrossRefGoogle Scholar
  13. Johanson G (1988) Aspects of biological monitoring of exposure to glycol ethers. Toxicol Lett 43: 5–21PubMedCrossRefGoogle Scholar
  14. Johanson G (1989) Analysis of ethylene glycol ether metabolites in urine by extractive alkylation and electron-capture gas chromatography. Arch Toxicol 63: 107–111PubMedCrossRefGoogle Scholar
  15. Johanson G, Boman A (1991) Percutaneous absorption of 2-butoxyethanol vapour in human subjects. Br J Ind Med 48: 788–792PubMedGoogle Scholar
  16. Johanson G, Dynesius B (1988) Liquid/air partition coefficients of six commonly used glycol ethers. Br J Ind Med 45: 561–564PubMedGoogle Scholar
  17. Johanson G, Fernström P (1986) Percutaneous uptake rate of 2-butoxyethanol in the guinea pig. Scand J Work Environ Health 12: 499–503PubMedGoogle Scholar
  18. Johanson G, Fernstöm P (1988) Influence of water on the percutaneous absorption of 2-butoxyethanol in guinea pigs. Scand J Work Environ Health 14: 95–100PubMedGoogle Scholar
  19. Johanson G, Johnsson S (1991) Gas chromatographic determination of butoxyacetic acid in human blood after exposure to 2-butoxyethanol. Arch Toxicol 65: 433–435PubMedCrossRefGoogle Scholar
  20. Johanson G, Kronborg H, Näslund PH, Byfält Nordqvist M (1986a) Toxicolinetics of inhaled 2-butoxyethanol (ethylene glycol monobutyl ether) in man. Scand J Work Environ Health 12: 594–602PubMedGoogle Scholar
  21. Johanson G, Wallén M, Byfält Nordqvist M (1986b) Elimination kinetics of 2-butoxyethanol in the perfused rat liver — dose dependence and effect of ethanol. Toxicol Appl Pharmacol 83: 315–320PubMedCrossRefGoogle Scholar
  22. Johanson G, Boman A, Dynesius B (1988) Percutaneous absoption of 2-butoxyethanol in man. Scand J Work Environ Health 14: 101–109PubMedGoogle Scholar
  23. Jönsson A-K, Steen G (1978) n-Butoxyacetic acid, a urinary metabolite from inhaled n-butoxyethanol (Butylcellosolve). Acta Pharmacol Toxicol (Copenh) 42: 354–356Google Scholar
  24. Krasavage WJ (1986) Subchronic oral toxicity of ethylene glycol monobutyl ether in male rats. Fundam Appl Toxicol 6: 349–355PubMedCrossRefGoogle Scholar
  25. Medinsky MA, Singh G, Bechtold WE, Bond JA, Sabourin PJ, Birnbaum LS, Henderson RF (1990) Disposition of three glycol ethers administered in drinking water to male F344/N rats. Toxicol Appl Pharmacol 102: 443–455PubMedCrossRefGoogle Scholar
  26. NIOSH (1990) Criteria for a recommended standard. Occupational exposure to ethylene glycol monobutyl ether and ethylene glycol monobutyl ether acetate, National Institute for Occupational Safety and Health, Cincinatti, Ohio, p 158Google Scholar
  27. Ruchaud S, Boiron O, Cicolella A, Lanotte M (1992) Ethylene glycol ethers as hemopoietic toxins — in vitro studies of acute exposure. Leukemia 6: 328–334PubMedGoogle Scholar
  28. Sabourin PJ, Medinsky MA, Birnbaum LS, Griffith WC, henderson RF (1992a) Effect of exposure concentration on the disposition of inhaled butoxyethanol by F344 rats. Toxicol Appl Pharmacol 114: 232–238PubMedCrossRefGoogle Scholar
  29. Sabourin PJ, Medinsky MA, Thurmond F, Birnbaum LS, Henderson RF (1992b) Effect of dose on the disposition of methoxyethanol, ethoxyethanol, and butoxyethanol administered dermally to male F344/N rats. Fundam Appl Toxicol 19: 124–132PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • Gunnar Johanson
    • 1
    • 2
  1. 1.Department of ToxicologyNational Institute of Occupational HealthSolnaSweden
  2. 2.Department of Occupational and Environmental MedicineUniversity HospitalUppsalaSweden

Personalised recommendations